0001209191-19-053681.txt : 20191021 0001209191-19-053681.hdr.sgml : 20191021 20191021153236 ACCESSION NUMBER: 0001209191-19-053681 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191018 FILED AS OF DATE: 20191021 DATE AS OF CHANGE: 20191021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castellanos Elaine CENTRAL INDEX KEY: 0001662520 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 191159593 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-18 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662520 Castellanos Elaine 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 0 1 0 0 Principal Accounting Officer Class A common stock 2019-10-18 4 C 0 2000 A 13933 D Class A common stock 2019-10-18 4 S 0 2000 170.00 D 11933 D Employee Stock Option (right to buy) 11.00 2019-10-18 4 M 0 2000 0.00 D 2026-05-25 Class B common stock 2000 18434 D Class B common stock 2019-10-18 4 M 0 2000 11.00 A Class A common stock 2000 2000 D Class B common stock 2019-10-18 4 C 0 2000 D Class A common stock 2000 0 D The exercise, conversion, and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. The options vest in sixteen equal quarterly installments beginning on August 25, 2016. /s/ Michael D. Wortley, attorney-in-fact 2019-10-21